Watch for Acid-Reducer Interactions With New Hep C Med Harvoni

Please see new warnings concerning the use of amiodarone with Harvoni or Sovaldi

    You'll see two new ORAL hepatitis C regimens...Harvoni (har-VOE-nee) and Olysio (simeprevir) PLUS Sovaldi (sofosbuvir).

   These new regimens are changing hep C therapy again...because they eliminate the need for ribavirin and interferon for most patients.

   Harvoni is a new once-daily tablet that combines Sovaldi with a new antiviral, ledipasvir.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote